Crossmark

Rheumatic diseases associated with immune checkpoint inhibitors in cancer immunotherapy

Crossref DOI link: https://doi.org/10.1080/14397595.2018.1532559

Published Online: 2018-12-20

Published Print: 2019-09-03

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Ohnuma, Kei

Hatano, Ryo

Dang, Nam H.

Morimoto, Chikao
Funding

Funding for this research was provided by:

Ministry of Health, Labour, and Welfare, Japan (150401-01, 180101-01)

JSPS KAKENHI (JP16H05345, JP18H02782, JP17K10008)
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=imor20

Publication History

Received: 2018-07-19

Accepted: 2018-10-01

Published: 2018-12-20